Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A generous gift of £3.5 million from Lakshmi Mittal and his family has secured the future of a critical professorship in vaccinology at the University. The post, which is currently held by Professor Adrian Hill, will be known as the Lakshmi Mittal and Family Professorship of Vaccinology in recognition of this support.

Photo of Professor Adrian Hill © Photo by John Cairns
Professor Adrian Hill at the Jenner Institute

Professor Hill is the Director of the Oxford Jenner Institute, now the largest academic vaccine centre in the world. In 2014 Professor Hill led the first clinical trial of a vaccine aimed at controlling the Ebola outbreak in West Africa, thus kickstarting an initiative at the Jenner Institute to develop vaccines for outbreak pathogens. Recently this programme has facilitated a major effort to rapidly develop a COVID-19 vaccine, with Professor Hill acting as principal investigator for the Oxford trial. The vaccine is currently undergoing human trials in the United Kingdom, Brazil and South Africa.

As well as leading the institute, Professor Hill’s own vaccine research programme has developed one of the most promising potential vaccines for malaria, which is currently in large-scale trials in sub-Saharan Africa.

Boosted by a further £1.75 million in matched funding from the University, the Mittal family’s gift has enabled the permanent endowment of the post. Not only will this allow Professor Hill to continue with his vital research, but will also help to ensure that Oxford remains at the forefront of vaccine development for generations to come.

The full story is available on the University of Oxford Development Office website

Similar stories

Oxford University academics recognised in Queen’s Birthday Honours

The pioneering work of members of the University, including research into tackling the Coronavirus pandemic, has been recognised in The Queen's Birthday Honours List.

Two Oxford Professors elected as EMBO Members

Professor Robert Klose and Professor Ervin Fodor are two of 64 life scientists to be elected to The European Molecular Biology Organization (EMBO).

Scientists make DNA breakthrough which could identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine at Oxford University have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

AI endoscopy enables 3D surface measurements of pre-cancerous condition in oesophagus

Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer.

The COVID-19 International Modelling Consortium (CoMo Consortium) enters a new phase

Created in March 2020 to assist policymakers to make use of existing evidence in mathematical and epidemiological models to inform strategies for minimising the impact of COVID-19, the CoMo Consortium brings together mathematical modellers, epidemiologists, health economists and public health experts from more than 40 countries across Africa, Asia and South and North America.

New Head of the Department of Psychiatry – Professor Belinda Lennox

Professor Belinda Lennox has been welcomed to the role of Head of the Department of Psychiatry at the University of Oxford and will take over leadership in October 2021.